With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.